REGULATED PRESS RELEASE published on 01/18/2024 at 18:46, 8 months 10 days ago Covivio: half-year liquidity contract reporting at 31 December 2023 The half-yearly report on the COVIVIO liquidity contract reveals the allocation of resources to the liquidity account, the negotiations during the second semester 2023, and the daily report for the period from 01/07/2023 to 31/12/2023. COVIVIO, a leading real estate player at the European level, emphasizes sustainable relationships, well-being, and responsible performance as part of its Purpose. Its shares listed in the Euronext Paris A compartment are included in various indices and hold multiple awards and ratings. COVIVIO Liquidity Contract Real Estate Expertise European Culture Sustainable Relationships Responsible Performance
REGULATED PRESS RELEASE published on 11/07/2023 at 19:05, 10 months 21 days ago Covivio and AccorInvest enter into exclusive negotiations with a view to consolidating their hotel properties and business assets
REGULATED PRESS RELEASE published on 10/20/2023 at 18:00, 11 months 8 days ago Transfer of Covivio's liquidity contract by EXANE to BNP PARIBAS ARBITRAGE
REGULATED PRESS RELEASE published on 10/19/2023 at 18:00, 11 months 9 days ago Covivio - Activity at end-September 2023: Stronger balance sheet and revenues up +7% like-for-like
Published on 09/28/2024 at 02:06, 20 hours 12 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 20 hours 18 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 20 hours 18 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 22 hours 8 minutes ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 8 hours 17 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 23 hours 48 minutes ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 3 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 3 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 4 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 4 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 4 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 4 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024